Hvem vi hjelperVår vitenskapProdukterResultater
Logg innSpørKom i gangfra 449 $
Egenskap
Weight loss
Reduction of total body weight.
Sammendrag
- Også kalt
- Loss of weight
- Kroppssystem
- Growth abnormality
Hvem vi hjelperVår vitenskapProdukterResultater
Logg innSpørKom i gangfra 449 $
This page as data
Add .json to the page's address, or ask for application/json, to read it as JSON.
library(jsonlite)
url <- "https://dantelabs.com/traits/weight-loss.json"
page <- fromJSON(url)
page$trait$nameWeight lossHP:0001824
Hvem vi hjelperVår vitenskapProdukterResultater
Logg innSpørKom i gangfra 449 $
Les genene knyttet til Weight loss, og resten av genomet ditt, med én test.
Fra 449 $Gratis frakt · Resultater på 6–8 uker
Få mitt Genome Test353 gener knyttet til Weight loss
Endringer i disse genene forårsaker sjeldne tilstander der Weight loss forekommer. De fleste med denne egenskapen har ingen av disse tilstandene, og et gen på denne listen sier ingenting om noens eget genom.
| Gen | Hvor ofte den forekommer | Tilstander |
|---|---|---|
| ABCB7ATP binding cassette subfamily B member 7 | Alltid | I 1 tilstand |
| CTNScystinosin, lysosomal cystine transporter | Alltid | I 1 tilstand |
| FLNAfilamin A | Alltid | I 1 tilstand |
| KCNJ18potassium inwardly rectifying channel subfamily J member 18 | Alltid | I 2 tilstander |
| KLF1KLF transcription factor 1 | Alltid | I 1 tilstand |
| POLGDNA polymerase gamma, catalytic subunit | Alltid | I 4 tilstander |
| PTCRApre T cell antigen receptor alpha | Alltid | I 1 tilstand |
| TYMPthymidine phosphorylase | Alltid | I 2 tilstander |
| ABCC8ATP binding cassette subfamily C member 8 | Svært ofte (80–99 %) | I 1 tilstand |
| ABCD3ATP binding cassette subfamily D member 3 | Svært ofte (80–99 %) | I 1 tilstand |
| ATMATM serine/threonine kinase | Svært ofte (80–99 %) | I 2 tilstander |
| ATP7BATPase copper transporting beta | Svært ofte (80–99 %) | I 1 tilstand |
| BANK1B cell scaffold protein with ankyrin repeats 1 | Svært ofte (80–99 %) | I 1 tilstand |
| BCL10BCL10 immune signaling adaptor | Svært ofte (80–99 %) | I 1 tilstand |
| BCL2BCL2 apoptosis regulator | Svært ofte (80–99 %) | I 1 tilstand |
| BCL6BCL6 transcription repressor | Svært ofte (80–99 %) | I 1 tilstand |
| BIRC3baculoviral IAP repeat containing 3 | Svært ofte (80–99 %) | I 1 tilstand |
| BLKBLK proto-oncogene, Src family tyrosine kinase | Svært ofte (80–99 %) | I 1 tilstand |
| BMPR1Abone morphogenetic protein receptor type 1A | Svært ofte (80–99 %) | I 1 tilstand |
| BRCA1BRCA1 DNA repair associated | Svært ofte (80–99 %) | I 2 tilstander |
| BRCA2BRCA2 DNA repair associated | Svært ofte (80–99 %) | I 4 tilstander |
| C4Acomplement C4A (Chido/Rodgers blood group) | Svært ofte (80–99 %) | I 2 tilstander |
| C4Bcomplement C4B (Chido/Rodgers blood group) | Svært ofte (80–99 %) | I 1 tilstand |
| CDKN2Acyclin dependent kinase inhibitor 2A | Svært ofte (80–99 %) | I 2 tilstander |
| CHEK2checkpoint kinase 2 | Svært ofte (80–99 %) | I 2 tilstander |
| CR2complement C3d receptor 2 | Svært ofte (80–99 %) | I 1 tilstand |
| CTLA4cytotoxic T-lymphocyte associated protein 4 | Svært ofte (80–99 %) | I 3 tilstander |
| DCTN1dynactin subunit 1 | Svært ofte (80–99 %) | I 3 tilstander |
| DNASE1deoxyribonuclease 1 | Svært ofte (80–99 %) | I 1 tilstand |
| EPCAMepithelial cell adhesion molecule | Svært ofte (80–99 %) | I 2 tilstander |
| ETS1ETS proto-oncogene 1, transcription factor | Svært ofte (80–99 %) | I 1 tilstand |
| FCGR2BFc gamma receptor IIb | Svært ofte (80–99 %) | I 1 tilstand |
| FCGR3BFc gamma receptor IIIb | Svært ofte (80–99 %) | I 1 tilstand |
| FOXP1forkhead box P1 | Svært ofte (80–99 %) | I 1 tilstand |
| GCKglucokinase | Svært ofte (80–99 %) | I 1 tilstand |
| GIPC1GIPC PDZ domain containing family member 1 | Svært ofte (80–99 %) | I 1 tilstand |
| GJA1gap junction protein alpha 1 | Svært ofte (80–99 %) | I 1 tilstand |
| GJB3gap junction protein beta 3 | Svært ofte (80–99 %) | I 1 tilstand |
| GJB4gap junction protein beta 4 | Svært ofte (80–99 %) | I 1 tilstand |
| HLA-Bmajor histocompatibility complex, class I, B | Svært ofte (80–99 %) | I 5 tilstander |
Vis 313 gener til
| Gen | Hvor ofte den forekommer | Tilstander |
|---|---|---|
| HLA-DPA1major histocompatibility complex, class II, DP alpha 1 | Svært ofte (80–99 %) | I 1 tilstand |
| HLA-DPB1major histocompatibility complex, class II, DP beta 1 | Svært ofte (80–99 %) | I 2 tilstander |
| HLA-DQB1major histocompatibility complex, class II, DQ beta 1 | Svært ofte (80–99 %) | I 3 tilstander |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Svært ofte (80–99 %) | I 7 tilstander |
| HLCSholocarboxylase synthetase | Svært ofte (80–99 %) | I 1 tilstand |
| IGHimmunoglobulin heavy locus | Svært ofte (80–99 %) | I 3 tilstander |
| IGHG1immunoglobulin heavy constant gamma 1 (G1m marker) | Svært ofte (80–99 %) | I 1 tilstand |
| IKZF1IKAROS family zinc finger 1 | Svært ofte (80–99 %) | I 1 tilstand |
| IL10interleukin 10 | Svært ofte (80–99 %) | I 3 tilstander |
| IL12Binterleukin 12B | Svært ofte (80–99 %) | I 1 tilstand |
| INSinsulin | Svært ofte (80–99 %) | I 1 tilstand |
| IRAK1interleukin 1 receptor associated kinase 1 | Svært ofte (80–99 %) | I 1 tilstand |
| IRF5interferon regulatory factor 5 | Svært ofte (80–99 %) | I 1 tilstand |
| ITGAMintegrin subunit alpha M | Svært ofte (80–99 %) | I 1 tilstand |
| JAK2Janus kinase 2 | Svært ofte (80–99 %) | I 3 tilstander |
| JAZF1JAZF zinc finger 1 | Svært ofte (80–99 %) | I 1 tilstand |
| KCNJ11potassium inwardly rectifying channel subfamily J member 11 | Svært ofte (80–99 %) | I 1 tilstand |
| KDSR3-ketodihydrosphingosine reductase | Svært ofte (80–99 %) | I 1 tilstand |
| KIAA0319LKIAA0319 like | Svært ofte (80–99 %) | I 1 tilstand |
| KRASKRas proto-oncogene, GTPase | Svært ofte (80–99 %) | I 2 tilstander |
| KRT1keratin 1 | Svært ofte (80–99 %) | I 1 tilstand |
| KRT10keratin 10 | Svært ofte (80–99 %) | I 1 tilstand |
| LMNAlamin A/C | Svært ofte (80–99 %) | I 1 tilstand |
| LPIN2lipin 2 | Svært ofte (80–99 %) | I 1 tilstand |
| LRP12LDL receptor related protein 12 | Svært ofte (80–99 %) | I 3 tilstander |
| MALT1MALT1 paracaspase | Svært ofte (80–99 %) | I 1 tilstand |
| MECP2methyl-CpG binding protein 2 | Svært ofte (80–99 %) | I 1 tilstand |
| MLH1mutL homolog 1 | Svært ofte (80–99 %) | I 1 tilstand |
| MLXMAX dimerization protein MLX | Svært ofte (80–99 %) | I 1 tilstand |
| MSH2mutS homolog 2 | Svært ofte (80–99 %) | I 1 tilstand |
| MSH6mutS homolog 6 | Svært ofte (80–99 %) | I 1 tilstand |
| MUTYHmutY DNA glycosylase | Svært ofte (80–99 %) | I 1 tilstand |
| NOTCH2NLCnotch 2 N-terminal like C | Svært ofte (80–99 %) | I 1 tilstand |
| NPATnuclear protein, coactivator of histone transcription | Svært ofte (80–99 %) | I 1 tilstand |
| NUTM2B-AS1NUTM2B antisense RNA 1 | Svært ofte (80–99 %) | I 1 tilstand |
| P4HA2prolyl 4-hydroxylase subunit alpha 2 | Svært ofte (80–99 %) | I 1 tilstand |
| PALB2partner and localizer of BRCA2 | Svært ofte (80–99 %) | I 2 tilstander |
| PALLDpalladin, cytoskeletal associated protein | Svært ofte (80–99 %) | I 1 tilstand |
| PDCD1programmed cell death 1 | Svært ofte (80–99 %) | I 1 tilstand |
| PDX1pancreatic and duodenal homeobox 1 | Svært ofte (80–99 %) | I 1 tilstand |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Svært ofte (80–99 %) | I 1 tilstand |
| PMS1PMS1 homolog 1, mismatch repair system component | Svært ofte (80–99 %) | I 1 tilstand |
| PMS2PMS1 homolog 2, mismatch repair system component | Svært ofte (80–99 %) | I 1 tilstand |
| POLD1DNA polymerase delta 1, catalytic subunit | Svært ofte (80–99 %) | I 1 tilstand |
| POLEDNA polymerase epsilon, catalytic subunit | Svært ofte (80–99 %) | I 1 tilstand |
| PRTN3proteinase 3 | Svært ofte (80–99 %) | I 1 tilstand |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Svært ofte (80–99 %) | I 4 tilstander |
| PXKPX domain containing serine/threonine kinase like | Svært ofte (80–99 %) | I 1 tilstand |
| RABL3RAB, member of RAS oncogene family like 3 | Svært ofte (80–99 %) | I 1 tilstand |
| RILPL1Rab interacting lysosomal protein like 1 | Svært ofte (80–99 %) | I 1 tilstand |
| RPS20ribosomal protein S20 | Svært ofte (80–99 %) | I 1 tilstand |
| SEMA4Asemaphorin 4A | Svært ofte (80–99 %) | I 1 tilstand |
| SLC5A1solute carrier family 5 member 1 | Svært ofte (80–99 %) | I 1 tilstand |
| SMAD4SMAD family member 4 | Svært ofte (80–99 %) | I 1 tilstand |
| SPP1secreted phosphoprotein 1 | Svært ofte (80–99 %) | I 1 tilstand |
| STAT3signal transducer and activator of transcription 3 | Svært ofte (80–99 %) | I 2 tilstander |
| STAT4signal transducer and activator of transcription 4 | Svært ofte (80–99 %) | I 3 tilstander |
| TGFBR2transforming growth factor beta receptor 2 | Svært ofte (80–99 %) | I 1 tilstand |
| TLR7toll like receptor 7 | Svært ofte (80–99 %) | I 1 tilstand |
| TNFAIP3TNF alpha induced protein 3 | Svært ofte (80–99 %) | I 1 tilstand |
| TNFSF4TNF superfamily member 4 | Svært ofte (80–99 %) | I 1 tilstand |
| TNIP1TNFAIP3 interacting protein 1 | Svært ofte (80–99 %) | I 1 tilstand |
| TP53tumor protein p53 | Svært ofte (80–99 %) | I 3 tilstander |
| TREX1three prime repair exonuclease 1 | Svært ofte (80–99 %) | I 1 tilstand |
| TSHRthyroid stimulating hormone receptor | Svært ofte (80–99 %) | I 2 tilstander |
| UBE2L3ubiquitin conjugating enzyme E2 L3 | Svært ofte (80–99 %) | I 1 tilstand |
| ZMPSTE24zinc metallopeptidase STE24 | Svært ofte (80–99 %) | I 1 tilstand |
| AAASaladin WD repeat nucleoporin | Ofte (30–79 %) | I 1 tilstand |
| ABCD1ATP binding cassette subfamily D member 1 | Ofte (30–79 %) | I 1 tilstand |
| ACTA1actin alpha 1, skeletal muscle | Ofte (30–79 %) | I 1 tilstand |
| AK2adenylate kinase 2 | Ofte (30–79 %) | I 1 tilstand |
| ALKALK receptor tyrosine kinase | Ofte (30–79 %) | I 1 tilstand |
| ANGangiogenin | Ofte (30–79 %) | I 1 tilstand |
| ANO1anoctamin 1 | Ofte (30–79 %) | I 1 tilstand |
| ANXA11annexin A11 | Ofte (30–79 %) | I 1 tilstand |
| ASXL1ASXL transcriptional regulator 1 | Ofte (30–79 %) | I 2 tilstander |
| ATP7AATPase copper transporting alpha | Ofte (30–79 %) | I 1 tilstand |
| ATRXATRX chromatin remodeler | Ofte (30–79 %) | I 1 tilstand |
| ATXN2ataxin 2 | Ofte (30–79 %) | I 1 tilstand |
| AVParginine vasopressin | Ofte (30–79 %) | I 1 tilstand |
| B2Mbeta-2-microglobulin | Ofte (30–79 %) | I 1 tilstand |
| BAP1BRCA1 associated deubiquitinase 1 | Ofte (30–79 %) | I 1 tilstand |
| BCORBCL6 corepressor | Ofte (30–79 %) | I 1 tilstand |
| BTNL2butyrophilin like 2 | Ofte (30–79 %) | I 1 tilstand |
| CACNA1Scalcium voltage-gated channel subunit alpha1 S | Ofte (30–79 %) | I 2 tilstander |
| CBLCbl proto-oncogene | Ofte (30–79 %) | I 1 tilstand |
| CCND1cyclin D1 | Ofte (30–79 %) | I 2 tilstander |
| CCNFcyclin F | Ofte (30–79 %) | I 1 tilstand |
| CDC73cell division cycle 73 | Ofte (30–79 %) | I 1 tilstand |
| CDH23cadherin related 23 | Ofte (30–79 %) | I 1 tilstand |
| CDKN1Bcyclin dependent kinase inhibitor 1B | Ofte (30–79 %) | I 1 tilstand |
| CDKN2Bcyclin dependent kinase inhibitor 2B | Ofte (30–79 %) | I 1 tilstand |
| CFAP410cilia and flagella associated protein 410 | Ofte (30–79 %) | I 1 tilstand |
| CHCHD10coiled-coil-helix-coiled-coil-helix domain containing 10 | Ofte (30–79 %) | I 1 tilstand |
| CHMP2Bcharged multivesicular body protein 2B | Ofte (30–79 %) | I 1 tilstand |
| CRLF1cytokine receptor like factor 1 | Ofte (30–79 %) | I 1 tilstand |
| CTNNB1catenin beta 1 | Ofte (30–79 %) | I 1 tilstand |
| DAOD-amino acid oxidase | Ofte (30–79 %) | I 1 tilstand |
| DLSTdihydrolipoamide S-succinyltransferase | Ofte (30–79 %) | I 1 tilstand |
| DNMT3ADNA methyltransferase 3 alpha | Ofte (30–79 %) | I 1 tilstand |
| ECE1endothelin converting enzyme 1 | Ofte (30–79 %) | I 1 tilstand |
| EDN3endothelin 3 | Ofte (30–79 %) | I 1 tilstand |
| EDNRBendothelin receptor type B | Ofte (30–79 %) | I 1 tilstand |
| EHHADHenoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase | Ofte (30–79 %) | I 1 tilstand |
| ELF4E74 like ETS transcription factor 4 | Ofte (30–79 %) | I 1 tilstand |
| EPAS1endothelial PAS domain protein 1 | Ofte (30–79 %) | I 1 tilstand |
| ERBB2erb-b2 receptor tyrosine kinase 2 | Ofte (30–79 %) | I 1 tilstand |
| ERBB3erb-b2 receptor tyrosine kinase 3 | Ofte (30–79 %) | I 1 tilstand |
| ERBB4erb-b2 receptor tyrosine kinase 4 | Ofte (30–79 %) | I 1 tilstand |
| EWSR1EWS RNA binding protein 1 | Ofte (30–79 %) | I 1 tilstand |
| FHfumarate hydratase | Ofte (30–79 %) | I 1 tilstand |
| FIG4FIG4 phosphoinositide 5-phosphatase | Ofte (30–79 %) | I 1 tilstand |
| FIP1L1factor interacting with PAPOLA and CPSF1 | Ofte (30–79 %) | I 1 tilstand |
| FUSFUS RNA binding protein | Ofte (30–79 %) | I 1 tilstand |
| GABRA3gamma-aminobutyric acid type A receptor subunit alpha3 | Ofte (30–79 %) | I 1 tilstand |
| GATA2GATA binding protein 2 | Ofte (30–79 %) | I 1 tilstand |
| GATA4GATA binding protein 4 | Ofte (30–79 %) | I 1 tilstand |
| GATMglycine amidinotransferase | Ofte (30–79 %) | I 1 tilstand |
| GDNFglial cell derived neurotrophic factor | Ofte (30–79 %) | I 1 tilstand |
| GLE1GLE1 RNA export mediator | Ofte (30–79 %) | I 1 tilstand |
| GLT8D1glycosyltransferase 8 domain containing 1 | Ofte (30–79 %) | I 1 tilstand |
| GMPPAGDP-mannose pyrophosphorylase A | Ofte (30–79 %) | I 1 tilstand |
| GPR35G protein-coupled receptor 35 | Ofte (30–79 %) | I 1 tilstand |
| HACD13-hydroxyacyl-CoA dehydratase 1 | Ofte (30–79 %) | I 1 tilstand |
| HACE1HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1 | Ofte (30–79 %) | I 1 tilstand |
| HAVCR2hepatitis A virus cellular receptor 2 | Ofte (30–79 %) | I 1 tilstand |
| HLA-DQA1major histocompatibility complex, class II, DQ alpha 1 | Ofte (30–79 %) | I 2 tilstander |
| HNRNPA1heterogeneous nuclear ribonucleoprotein A1 | Ofte (30–79 %) | I 1 tilstand |
| HTThuntingtin | Ofte (30–79 %) | I 2 tilstander |
| IRF2BP2interferon regulatory factor 2 binding protein 2 | Ofte (30–79 %) | I 1 tilstand |
| ITGA7integrin subunit alpha 7 | Ofte (30–79 %) | I 1 tilstand |
| KIF1Bkinesin family member 1B | Ofte (30–79 %) | I 2 tilstander |
| KITKIT proto-oncogene, receptor tyrosine kinase | Ofte (30–79 %) | I 1 tilstand |
| LIG3DNA ligase 3 | Ofte (30–79 %) | I 1 tilstand |
| LIN28Blin-28 RNA binding posttranscriptional regulator B | Ofte (30–79 %) | I 1 tilstand |
| LMO1LIM domain only 1 | Ofte (30–79 %) | I 1 tilstand |
| MAP3K20mitogen-activated protein kinase kinase kinase 20 | Ofte (30–79 %) | I 1 tilstand |
| MATR3matrin 3 | Ofte (30–79 %) | I 1 tilstand |
| MAXMYC associated transcriptional regulator X | Ofte (30–79 %) | I 1 tilstand |
| MC2Rmelanocortin 2 receptor | Ofte (30–79 %) | I 1 tilstand |
| MDH2malate dehydrogenase 2 | Ofte (30–79 %) | I 1 tilstand |
| MEN1menin 1 | Ofte (30–79 %) | I 1 tilstand |
| MRAPmelanocortin 2 receptor accessory protein | Ofte (30–79 %) | I 1 tilstand |
| MST1macrophage stimulating 1 | Ofte (30–79 %) | I 1 tilstand |
| MYCNMYCN proto-oncogene, bHLH transcription factor | Ofte (30–79 %) | I 1 tilstand |
| MYL2myosin light chain 2 | Ofte (30–79 %) | I 1 tilstand |
| NABP1nucleic acid binding protein 1 | Ofte (30–79 %) | I 1 tilstand |
| NDUFAF6NADH:ubiquinone oxidoreductase complex assembly factor 6 | Ofte (30–79 %) | I 1 tilstand |
| NEFHneurofilament heavy chain | Ofte (30–79 %) | I 1 tilstand |
| NEK1NIMA related kinase 1 | Ofte (30–79 %) | I 1 tilstand |
| NF1neurofibromin 1 | Ofte (30–79 %) | I 1 tilstand |
| NNTnicotinamide nucleotide transhydrogenase | Ofte (30–79 %) | I 1 tilstand |
| NOD2nucleotide binding oligomerization domain containing 2 | Ofte (30–79 %) | I 2 tilstander |
| NOS1nitric oxide synthase 1 | Ofte (30–79 %) | I 1 tilstand |
| NPM1nucleophosmin 1 | Ofte (30–79 %) | I 1 tilstand |
| NRTNneurturin | Ofte (30–79 %) | I 1 tilstand |
| NUMA1nuclear mitotic apparatus protein 1 | Ofte (30–79 %) | I 1 tilstand |
| OPTNoptineurin | Ofte (30–79 %) | I 1 tilstand |
| PFN1profilin 1 | Ofte (30–79 %) | I 1 tilstand |
| PHOX2Bpaired like homeobox 2B | Ofte (30–79 %) | I 1 tilstand |
| PIK3R1phosphoinositide-3-kinase regulatory subunit 1 | Ofte (30–79 %) | I 1 tilstand |
| PMLPML nuclear body scaffold | Ofte (30–79 %) | I 1 tilstand |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Ofte (30–79 %) | I 2 tilstander |
| PRPHperipherin | Ofte (30–79 %) | I 1 tilstand |
| RARAretinoic acid receptor alpha | Ofte (30–79 %) | I 1 tilstand |
| RETret proto-oncogene | Ofte (30–79 %) | I 3 tilstander |
| RHBDF2rhomboid 5 homolog 2 | Ofte (30–79 %) | I 1 tilstand |
| RRM2Bribonucleotide reductase regulatory TP53 inducible subunit M2B | Ofte (30–79 %) | I 2 tilstander |
| RUNX1RUNX family transcription factor 1 | Ofte (30–79 %) | I 1 tilstand |
| SDHAsuccinate dehydrogenase complex flavoprotein subunit A | Ofte (30–79 %) | I 3 tilstander |
| SDHAF1succinate dehydrogenase complex assembly factor 1 | Ofte (30–79 %) | I 1 tilstand |
| SDHAF2succinate dehydrogenase complex assembly factor 2 | Ofte (30–79 %) | I 1 tilstand |
| SDHBsuccinate dehydrogenase complex iron sulfur subunit B | Ofte (30–79 %) | I 4 tilstander |
| SDHCsuccinate dehydrogenase complex subunit C | Ofte (30–79 %) | I 2 tilstander |
| SDHDsuccinate dehydrogenase complex subunit D | Ofte (30–79 %) | I 4 tilstander |
| SELENONselenoprotein N | Ofte (30–79 %) | I 1 tilstand |
| SEMA3Csemaphorin 3C | Ofte (30–79 %) | I 1 tilstand |
| SEMA3Dsemaphorin 3D | Ofte (30–79 %) | I 1 tilstand |
| SEMA4Dsemaphorin 4D | Ofte (30–79 %) | I 1 tilstand |
| SLC25A11solute carrier family 25 member 11 | Ofte (30–79 %) | I 1 tilstand |
| SLC2A3solute carrier family 2 member 3 | Ofte (30–79 %) | I 1 tilstand |
| SLC34A1solute carrier family 34 member 1 | Ofte (30–79 %) | I 1 tilstand |
| SMOsmoothened, frizzled class receptor | Ofte (30–79 %) | I 1 tilstand |
| SOD1superoxide dismutase 1 | Ofte (30–79 %) | I 1 tilstand |
| SQSTM1sequestosome 1 | Ofte (30–79 %) | I 1 tilstand |
| SREBF1sterol regulatory element binding transcription factor 1 | Ofte (30–79 %) | I 1 tilstand |
| SRSF2serine and arginine rich splicing factor 2 | Ofte (30–79 %) | I 2 tilstander |
| STARsteroidogenic acute regulatory protein | Ofte (30–79 %) | I 1 tilstand |
| STAT1signal transducer and activator of transcription 1 | Ofte (30–79 %) | I 1 tilstand |
| STAT5Bsignal transducer and activator of transcription 5B | Ofte (30–79 %) | I 1 tilstand |
| SYKspleen associated tyrosine kinase | Ofte (30–79 %) | I 1 tilstand |
| TAF15TATA-box binding protein associated factor 15 | Ofte (30–79 %) | I 1 tilstand |
| TARDBPTAR DNA binding protein | Ofte (30–79 %) | I 1 tilstand |
| TBK1TANK binding kinase 1 | Ofte (30–79 %) | I 1 tilstand |
| TBL1XR1TBL1X/Y related 1 | Ofte (30–79 %) | I 1 tilstand |
| TCF4transcription factor 4 | Ofte (30–79 %) | I 1 tilstand |
| TERTtelomerase reverse transcriptase | Ofte (30–79 %) | I 1 tilstand |
| TET2tet methylcytosine dioxygenase 2 | Ofte (30–79 %) | I 2 tilstander |
| TMEM127transmembrane protein 127 | Ofte (30–79 %) | I 1 tilstand |
| TPM2tropomyosin 2 | Ofte (30–79 %) | I 1 tilstand |
| TPM3tropomyosin 3 | Ofte (30–79 %) | I 1 tilstand |
| TRAPPC11trafficking protein particle complex subunit 11 | Ofte (30–79 %) | I 1 tilstand |
| TREM2triggering receptor expressed on myeloid cells 2 | Ofte (30–79 %) | I 1 tilstand |
| TTRtransthyretin | Ofte (30–79 %) | I 1 tilstand |
| TXNRD2thioredoxin reductase 2 | Ofte (30–79 %) | I 1 tilstand |
| UBQLN2ubiquilin 2 | Ofte (30–79 %) | I 1 tilstand |
| UNC13Aunc-13 homolog A | Ofte (30–79 %) | I 1 tilstand |
| VAPBVAMP associated protein B and C | Ofte (30–79 %) | I 1 tilstand |
| VCPvalosin containing protein | Ofte (30–79 %) | I 1 tilstand |
| VHLvon Hippel-Lindau tumor suppressor | Ofte (30–79 %) | I 2 tilstander |
| WT1WT1 transcription factor | Ofte (30–79 %) | I 2 tilstander |
| ZBTB16zinc finger and BTB domain containing 16 | Ofte (30–79 %) | I 1 tilstand |
| ZNRF3zinc and ring finger 3 | Ofte (30–79 %) | I 1 tilstand |
| ACAT1acetyl-CoA acetyltransferase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| AMNamnion associated transmembrane protein | Noen ganger (5–29 %) | I 1 tilstand |
| ANKRD55ankyrin repeat domain 55 | Noen ganger (5–29 %) | I 1 tilstand |
| BMP6bone morphogenetic protein 6 | Noen ganger (5–29 %) | I 1 tilstand |
| BRIP1BRCA1 interacting DNA helicase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| BTKBruton tyrosine kinase | Noen ganger (5–29 %) | I 1 tilstand |
| CALRcalreticulin | Noen ganger (5–29 %) | I 1 tilstand |
| CCR1C-C motif chemokine receptor 1 | Noen ganger (5–29 %) | I 1 tilstand |
| CD247CD247 molecule | Noen ganger (5–29 %) | I 1 tilstand |
| COL4A5collagen type IV alpha 5 chain | Noen ganger (5–29 %) | I 1 tilstand |
| COL4A6collagen type IV alpha 6 chain | Noen ganger (5–29 %) | I 1 tilstand |
| CTR9CTR9 component of Paf1/RNA polymerase II complex | Noen ganger (5–29 %) | I 1 tilstand |
| CTRCchymotrypsin C | Noen ganger (5–29 %) | I 1 tilstand |
| CUBNcubilin | Noen ganger (5–29 %) | I 1 tilstand |
| DIS3L2DIS3 like 3'-5' exoribonuclease 2 | Noen ganger (5–29 %) | I 1 tilstand |
| DNAJC13DnaJ heat shock protein family (Hsp40) member C13 | Noen ganger (5–29 %) | I 1 tilstand |
| EIF4G1eukaryotic translation initiation factor 4 gamma 1 | Noen ganger (5–29 %) | I 1 tilstand |
| ERAP1endoplasmic reticulum aminopeptidase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| ERCC4ERCC excision repair 4, endonuclease catalytic subunit | Noen ganger (5–29 %) | I 1 tilstand |
| F5coagulation factor V | Noen ganger (5–29 %) | I 1 tilstand |
| FAAP100FA core complex associated protein 100 | Noen ganger (5–29 %) | I 1 tilstand |
| FANCAFA complementation group A | Noen ganger (5–29 %) | I 1 tilstand |
| FANCBFA complementation group B | Noen ganger (5–29 %) | I 1 tilstand |
| FANCCFA complementation group C | Noen ganger (5–29 %) | I 1 tilstand |
| FANCD2FA complementation group D2 | Noen ganger (5–29 %) | I 1 tilstand |
| FANCEFA complementation group E | Noen ganger (5–29 %) | I 1 tilstand |
| FANCFFA complementation group F | Noen ganger (5–29 %) | I 1 tilstand |
| FANCGFA complementation group G | Noen ganger (5–29 %) | I 1 tilstand |
| FANCIFA complementation group I | Noen ganger (5–29 %) | I 1 tilstand |
| FANCLFA complementation group L | Noen ganger (5–29 %) | I 1 tilstand |
| FANCMFA complementation group M | Noen ganger (5–29 %) | I 1 tilstand |
| FASFas cell surface death receptor | Noen ganger (5–29 %) | I 1 tilstand |
| FLI1Fli-1 proto-oncogene, ETS transcription factor | Noen ganger (5–29 %) | I 1 tilstand |
| GALCgalactosylceramidase | Noen ganger (5–29 %) | I 1 tilstand |
| GBA1glucosylceramidase beta 1 | Noen ganger (5–29 %) | I 1 tilstand |
| GIGYF2GRB10 interacting GYF protein 2 | Noen ganger (5–29 %) | I 1 tilstand |
| GNPTABN-acetylglucosamine-1-phosphate transferase subunits alpha and beta | Noen ganger (5–29 %) | I 1 tilstand |
| GPC3glypican 3 | Noen ganger (5–29 %) | I 1 tilstand |
| H19H19 imprinted maternally expressed transcript | Noen ganger (5–29 %) | I 1 tilstand |
| HFEhomeostatic iron regulator | Noen ganger (5–29 %) | I 1 tilstand |
| HMGCL3-hydroxy-3-methylglutaryl-CoA lyase | Noen ganger (5–29 %) | I 1 tilstand |
| IFIH1interferon induced with helicase C domain 1 | Noen ganger (5–29 %) | I 1 tilstand |
| IFNGR1interferon gamma receptor 1 | Noen ganger (5–29 %) | I 2 tilstander |
| IL12Ainterleukin 12A | Noen ganger (5–29 %) | I 1 tilstand |
| IL12A-AS1IL12A antisense RNA 1 | Noen ganger (5–29 %) | I 1 tilstand |
| IL23Rinterleukin 23 receptor | Noen ganger (5–29 %) | I 1 tilstand |
| IL2RAinterleukin 2 receptor subunit alpha | Noen ganger (5–29 %) | I 1 tilstand |
| IL2RBinterleukin 2 receptor subunit beta | Noen ganger (5–29 %) | I 1 tilstand |
| IVDisovaleryl-CoA dehydrogenase | Noen ganger (5–29 %) | I 1 tilstand |
| JPH3junctophilin 3 | Noen ganger (5–29 %) | I 2 tilstander |
| KLRC4killer cell lectin like receptor C4 | Noen ganger (5–29 %) | I 1 tilstand |
| LRRK2leucine rich repeat kinase 2 | Noen ganger (5–29 %) | I 1 tilstand |
| MAD2L2mitotic arrest deficient 2 like 2 | Noen ganger (5–29 %) | I 1 tilstand |
| MAP2K1mitogen-activated protein kinase kinase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| MEFVMEFV innate immunity regulator, pyrin | Noen ganger (5–29 %) | I 1 tilstand |
| MPLMPL proto-oncogene, thrombopoietin receptor | Noen ganger (5–29 %) | I 1 tilstand |
| NAB2NGFI-A binding protein 2 | Noen ganger (5–29 %) | I 1 tilstand |
| NR0B1nuclear receptor subfamily 0 group B member 1 | Noen ganger (5–29 %) | I 1 tilstand |
| NRASNRAS proto-oncogene, GTPase | Noen ganger (5–29 %) | I 1 tilstand |
| PANK2pantothenate kinase 2 | Noen ganger (5–29 %) | I 1 tilstand |
| PKHD1PKHD1 ciliary IPT domain containing fibrocystin/polyductin | Noen ganger (5–29 %) | I 1 tilstand |
| POU6F2POU class 6 homeobox 2 | Noen ganger (5–29 %) | I 1 tilstand |
| PRNPprion protein (Kanno blood group) | Noen ganger (5–29 %) | I 4 tilstander |
| PSAPprosaposin | Noen ganger (5–29 %) | I 1 tilstand |
| PTPN2protein tyrosine phosphatase non-receptor type 2 | Noen ganger (5–29 %) | I 1 tilstand |
| RAD51RAD51 recombinase | Noen ganger (5–29 %) | I 1 tilstand |
| RAD51CRAD51 paralog C | Noen ganger (5–29 %) | I 1 tilstand |
| RESTRE1 silencing transcription factor | Noen ganger (5–29 %) | I 1 tilstand |
| RFWD3ring finger and WD repeat domain 3 | Noen ganger (5–29 %) | I 1 tilstand |
| RNF168ring finger protein 168 | Noen ganger (5–29 %) | I 1 tilstand |
| RNU7-1RNA, U7 small nuclear 1 | Noen ganger (5–29 %) | I 1 tilstand |
| SCNN1Asodium channel epithelial 1 subunit alpha | Noen ganger (5–29 %) | I 1 tilstand |
| SCNN1Bsodium channel epithelial 1 subunit beta | Noen ganger (5–29 %) | I 1 tilstand |
| SCNN1Gsodium channel epithelial 1 subunit gamma | Noen ganger (5–29 %) | I 1 tilstand |
| SLC34A2solute carrier family 34 member 2 | Noen ganger (5–29 %) | I 1 tilstand |
| SLC39A4solute carrier family 39 member 4 | Noen ganger (5–29 %) | I 1 tilstand |
| SLX4SLX4 structure-specific endonuclease subunit | Noen ganger (5–29 %) | I 1 tilstand |
| SNCAsynuclein alpha | Noen ganger (5–29 %) | I 2 tilstander |
| SPINK1serine peptidase inhibitor Kazal type 1 | Noen ganger (5–29 %) | I 1 tilstand |
| STAT6signal transducer and activator of transcription 6 | Noen ganger (5–29 %) | I 1 tilstand |
| THPOthrombopoietin | Noen ganger (5–29 %) | I 1 tilstand |
| TLR4toll like receptor 4 | Noen ganger (5–29 %) | I 1 tilstand |
| TRIM28tripartite motif containing 28 | Noen ganger (5–29 %) | I 1 tilstand |
| TRIP13thyroid hormone receptor interactor 13 | Noen ganger (5–29 %) | I 1 tilstand |
| TWNKtwinkle mtDNA helicase | Noen ganger (5–29 %) | I 1 tilstand |
| UBAC2UBA domain containing 2 | Noen ganger (5–29 %) | I 1 tilstand |
| UBE2Tubiquitin conjugating enzyme E2 T | Noen ganger (5–29 %) | I 1 tilstand |
| UNC45Aunc-45 myosin chaperone A | Noen ganger (5–29 %) | I 1 tilstand |
| VPS13Avacuolar protein sorting 13 homolog A | Noen ganger (5–29 %) | I 1 tilstand |
| VPS35VPS35 retromer complex component | Noen ganger (5–29 %) | I 1 tilstand |
| XRCC2X-ray repair cross complementing 2 | Noen ganger (5–29 %) | I 1 tilstand |
| CD28CD28 molecule | Sjelden (1–4%) | I 1 tilstand |
| RB1RB transcriptional corepressor 1 | Sjelden (1–4%) | I 1 tilstand |
| TNFRSF1BTNF receptor superfamily member 1B | Sjelden (1–4%) | I 1 tilstand |
| CD244CD244 molecule | Ikke registrert | I 1 tilstand |
| CIITAclass II major histocompatibility complex transactivator | Ikke registrert | I 1 tilstand |
| CYP24A1cytochrome P450 family 24 subfamily A member 1 | Ikke registrert | I 1 tilstand |
| IL6interleukin 6 | Ikke registrert | I 1 tilstand |
| NFKBIL1NFKB inhibitor like 1 | Ikke registrert | I 1 tilstand |
| SLC22A4solute carrier family 22 member 4 | Ikke registrert | I 1 tilstand |
Hvor ofte dette forekommer hos personer med en av genets tilstander, oppgitt som den hyppigste forekomsten blant dem, slik Human Phenotype Ontology registrerer den. Disse sidene beskriver egenskaper og forskningen bak dem. De er ikke en diagnose, og om symptomer bør du spørre lege eller genetisk rådgiver.
Smalere egenskaper
Bredere egenskaper
Slik er informasjonen samlet
- Human Phenotype Ontology, versjon 2026-09-01: egenskapen, navnene på den, definisjonen og genene som er knyttet til den. Les mer på hpo.jax.org.
- Datautgave 2026.10.16-c6eea6bf.
Hvem vi hjelperVår vitenskapProdukterResultater
Logg innSpørKom i gangfra 449 $
Én test. En livstid med svar.
Fra 449 $Gratis frakt · Resultater på 6–8 uker